Novel biomarker for determining disease activity or prognosis of facioscapulohumeral muscular dystrophy

WO2026096668A3PCT designated stage Publication Date: 2026-07-16AVIDITY BIOSCI INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
AVIDITY BIOSCI INC
Filing Date
2025-10-29
Publication Date
2026-07-16

Smart Images

  • Figure US2025053163_16072026_PF_FP_ABST
    Figure US2025053163_16072026_PF_FP_ABST
Patent Text Reader

Abstract

Disclosed herein is a novel biomarker and methods for determining the disease activity and prognosis of facioscapulohumeral muscular dystrophy (FSHD) using the novel biomarker.
Need to check novelty before this filing date? Find Prior Art